SECsense Logo

ESSA Pharma Inc. 8-K Report: Key Insights & Share Information

$EPIX
Form 8-K
Filed on: 2025-02-11
Source
ESSA Pharma Inc. 8-K Report: Key Insights & Share Information

Here are the key insights extracted from the provided section of the financial report:

  1. Entity Information:
  • Company Name: ESSA Pharma Inc.
  • CIK Number: 0001633932
  • SEC File Number: 001-37410
  • Tax ID: 98-1250703
  • Address: Suite 720, 999 West Broadway, Vancouver, BC, CA V5Z 1K5
  • Phone Number: 778-331-0962
  1. Filing Details:
  • Filing Type: 8-K (a report of unscheduled material events or corporate changes)
  • Filing Date: February 11, 2025
  1. Reporting Period:
  • As of Date: February 11, 2025
  • Reporting Period Start Date: February 11, 2025
  • Reporting Period End Date: February 11, 2025
  1. Share Information:
  • Type of Shares: Common Shares, no par value
  • Ticker Symbol: EPIX
  • Exchange: NASDAQ
  1. Measurement Units:
  • The report utilizes multiple measurement units including USD (United States Dollar) and shares.

This summary highlights essential company identification information, the nature of the filing, reporting dates, and share-related details, providing a clear snapshot of the financial report's key components.